Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint

TT Tang, X Cheng, B Truong, LZ Sun, XF Yang… - Pharmacology & …, 2021 - Elsevier
The CD40 receptor and its ligand CD40L is one of the most critical molecular pairs of the
stimulatory immune checkpoints. Both CD40 and CD40L have a membrane form and a …

Molecular mechanism and function of CD40/CD40L engagement in the immune system

R Elgueta, MJ Benson, VC De Vries… - Immunological …, 2009 - Wiley Online Library
During the generation of a successful adaptive immune response, multiple molecular
signals are required. A primary signal is the binding of cognate antigen to an antigen …

Agonistic CD40 antibodies and cancer therapy

RH Vonderheide, MJ Glennie - Clinical Cancer Research, 2013 - AACR
Recent success in cancer immunotherapy has reinvigorated the hypothesis that the immune
system can control many if not most cancers, in some cases producing durable responses in …

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

Y Chicheportiche, PR Bourdon, H Xu, YM Hsu… - Journal of Biological …, 1997 - ASBMB
The members of the tumor necrosis factor (TNF) family play pivotal roles in the regulation of
the immune system. Here we describe a new ligand in this family, designated TWEAK. The …

Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach

AN Chamseddine, T Assi, O Mir, S Chouaib - Pharmacology & therapeutics, 2022 - Elsevier
Tumor-associated macrophages (TAM) plasticity and diversity are both essential hallmarks
of the monocyte-macrophage lineage and the tumor-derived inflammation. TAM exemplify …

Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies

D Shan, JA Ledbetter, OW Press - Blood, The Journal of the …, 1998 - ashpublications.org
CD20 is a nonglycosylated 33 to 37 kD phosphoprotein involved in B-cell signaling that
subserves important functions in the regulation of B-cell proliferation and differentiation. In …

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors

AK Nowak, BWS Robinson, RA Lake - Cancer research, 2003 - AACR
Cytotoxic chemotherapy is generally considered immunosuppressive, with neutropenia and
lymphopenia being common adverse side effects. In this context, we have shown previously …

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

RR French, HT Chan, AL Tutt, MJ Glennie - Nature medicine, 1999 - nature.com
CD40 is essential in enabling antigen-presenting cells to process and present antigen
effectively to T cells. We demonstrate here that when antibody against CD40 is used to treat …

Characteristics and clinical trial results of agonistic anti‑CD40 antibodies in the treatment of malignancies

DK Li, W Wang - Oncology Letters, 2020 - spandidos-publications.com
Abstract Cluster of differentiation 40 (CD40) mediates many immune activities. Preclinical
studies have shown that activation of CD40 can evoke massive antineoplastic effects in …

Twelve immunotherapy drugs that could cure cancers

MA 'Mac'Cheever - Immunological reviews, 2008 - Wiley Online Library
Immune T cells can kill cancer cells. Cancer vaccines function by increasing the number of
immune T cells. There are exceedingly strict biologic limits imposed on the immune system …